Feasibility Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (150 mg/m2) Followed by Fluorouracil, Epirubicin, and Cyclophosphamide Therapy as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer
| Autor: | Kojima, Yasuyuki, Kawamoto, Hisanori, Nishikawa, Toru, Hayami, Ryosuke, Shimo, Arata, Haku, Ei, Akiyama, Kyoko, Tsugawa, Koichiro |
|---|---|
| Zdroj: | In Clinical Breast Cancer October 2018 18(5):374-379 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect